November 30, 2024 - 15:12

MARIETTA — Memorial Health System has announced the addition of Dr. Albeir Mousa, a highly qualified vascular surgeon, to its team at Marietta Memorial Hospital. Dr. Mousa brings a wealth of experience and expertise, enhancing the capabilities of the vascular team at MHS. His arrival is expected to significantly improve the level of care available to patients in the region.
Dr. Mousa is known for his proficiency in innovative vascular technologies and research, which will be instrumental in optimizing patient outcomes. His commitment to providing the highest quality of care aligns with the mission of Memorial Health System to deliver exceptional healthcare services to the community.
As he begins seeing patients, Dr. Mousa is poised to make a positive impact on the local healthcare landscape, ensuring that individuals in need of vascular care have access to the latest advancements and treatments available. The integration of his skills into the MHS team marks a promising development for patient care in the area.
May 28, 2026 - 03:00
Colorectal cancer risk linked to gut microbiome alterations | Harvard T.H. Chan School of Public HealthEven more than ten years after a precancerous growth called an adenoma is removed from the colon, the gut microbiome and its related metabolites may still show lasting changes that increase the...
May 27, 2026 - 14:17
A Great Athlete is a Healthy Athlete: Muaz’s Journey to Becoming a Fitness CaptainEvery May, Special Olympics marks Fitness and Sport Month, a time to highlight how physical activity boosts health, performance, and overall well-being for athletes. This year, I sat down with Muaz...
May 26, 2026 - 20:41
Popular fruit may help protect your skin from the sun, new study suggestsA new study suggests that eating grapes might offer a natural layer of protection against the sun`s harmful rays. Published in the journal ACS Nutrition Science, the research indicates that...
May 26, 2026 - 16:16
Optima Health Leads These 3 Undiscovered Gems in the United KingdomAs the FTSE 100 and FTSE 250 struggle under pressure from weak global signals and disappointing trade numbers out of China, many investors are shifting their attention away from big-name blue chips...